Related Experiment Videos
Hepatitis B virus core particles as epitope carriers
P Pumpens1, G P Borisova, R A Crowther
1Biomedical Research and Study Centre, University of Latvia, Riga.
Intervirology
|January 1, 1995
Summary
Hepatitis B core (HBc) particles serve as versatile carriers for foreign peptide insertion. Researchers explored HBc
Area of Science:
- Biotechnology
- Virology
- Immunology
Background:
- The Hepatitis B core (HBc) particle is a well-established particulate carrier for displaying foreign peptide sequences.
- Recombinant HBc protein can be expressed and correctly folded in various cell systems, including bacterial, yeast, insect, and mammalian cells.
- The unique assembly properties and structure of HBc particles facilitate substantial insertions without compromising capsid formation.
Purpose of the Study:
- To investigate the potential of HBc particles as carriers for foreign peptide insertion.
- To identify optimal sites within the HBc structure for foreign epitope display.
- To evaluate the immunological activity of inserted epitopes displayed on HBc particles.
Main Methods:
- Construction of display vectors based on the cloned HBc gene.
- Insertion of foreign epitope sequences into targeted regions of the HBc primary structure (N- and C-termini, immunodominant loop).
- Expression of recombinant HBc particles in various host cells.
- Analysis of capsid assembly and immunological activity of displayed epitopes.
Main Results:
- Substantial insertions of foreign peptide sequences into HBc particles are possible without loss of capsid-forming ability.
- The N-terminal, C-terminal, and immunodominant loop regions are suitable targets for foreign epitope insertion.
- Displayed epitopes retained, and in some cases, enhanced their original immunological activity.
- A range of viral and nonviral epitope sequences were successfully displayed.
Conclusions:
- HBc particles are highly effective and versatile carriers for displaying foreign peptide sequences and epitopes.
- The HBc display system offers a robust platform for immunological studies and potential vaccine development.
- Targeted modifications of HBc particles allow for the preservation and enhancement of the displayed epitope's immunogenicity.